Despite transient regression of the tumor, along with corresponding increases in cytokines and immune cell levels in the cerebrospinal fluid, patients died, most likely due to downregulation of the target antigen IL13Rα2 [804]. The gene discussed is IL13RA2; the disease is neoplasm.